Delivery Order SPE2DB20D1109-SPE2DB24FN04C

Award Date 11/7/23
Potential Completion Date 11/8/23
Potential Value $1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,769.54 firm fixed-price delivery order contract is for the provision of testosterone cypionate 200 mg/mL, a specialty medication. The contract has an ultimate completion date of June 5, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,351.65 firm fixed-price delivery order is for the supply of testosterone cypionate 200 mg/mL, a specialty medication. The contract has an ultimate completion date of December 20, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award, valued at $1,416.00, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of Testosterone Cypionate 200 mg/mL, a testosterone replacement therapy medication. The contract has an ultimate completion date of March 7, 2025 and uses a Firm Fixed Price pricing type. It is not designated with a set-aside requirement, indicating...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the delivery of testosterone cypionate 200 mg/ml. The $1,358.10 firm fixed-price contract has a completion date of March 31, 2025 and is not designated as a set-aside contract. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026 to provide a comprehensive range of...
This federal contract award, with ID SPE2DB20D1100|SPE2DB25FA8P1, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,599.84, is for the delivery of testosterone cypionate 200 mg/ml medication. It is a firm fixed price delivery order contract with a completion date of March 3, 2025. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award is for the delivery of testosterone cypionate 200 mg/mL pharmaceutical products to the Defense Logistics Agency (DLA) Troop Support Medical. The award, with a ceiling value of $1,103.74, was made to Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical distributor. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of August 19, 2024. It is not associated with a set-aside designation. Amerisourcebergen holds...
This federal contract award, valued at $1,212.07, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of testosterone cypionate 200 mg/mL, a specialty medication. This award is a delivery order under a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for...
This federal contract award, valued at $2,172.48, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of Testosterone Cypionate 200 mg/mL, a testosterone replacement therapy medication. The contract has an ultimate completion date of March 24, 2025 and uses a Firm Fixed Price pricing type. Amerisourcebergen holds a significant Indefinite Delivery...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Testosterone Cypionate 200 mg/mL. The contract has a ceiling value of $5,583.15 and is a Firm Fixed Price delivery order with an ultimate completion date of August 22, 2024. The contract is not a set-aside and was awarded on August 21, 2024. AmerisourceBergen Drug Corp's Corporate Office division is the awardee and is a for-profit...
This federal contract award is for the delivery of testosterone cypionate 200 mg/mL to the Defense Logistics Agency (DLA). The $1,860.86 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on December 4, 2024 with a completion date of December 5, 2024. The contract is not designated with any set-aside requirements. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
  • SPE2DB20D1109
    Indefinite Delivery Contract
  • SPE2DB20D1109-SPE2DB24FN04C
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Testosterone Cypionate 200 mg/mL. The contract has a ceiling value of $1,009.20 and a completion date of November 8, 2023. It is a firm fixed-price delivery order contract type. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract also encompasses the Department of Justice Federal Bureau of Investigation, with a separate IDC valued at $750,000 through May 2024, covering similar medical products and prescription drugs. This contract award does not have a set-aside designation, indicating open competition.

Generated 2/27/25, 12:18 PM